Top Markets
Coin of the day
IMBdx IMBdx

IMBdx

461030
Rank in Stocks #27702
IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for... IMBdx, Inc. specializes in developing advanced liquid biopsy technologies for cancer detection and management. The company's core mission revolves around three key areas: facilitating the diagnosis and treatment strategies for advanced-stage cancers, enabling the early identification of cancer recurrence after surgical interventions, and providing solutions for the early diagnosis of cancer. Its notable product offerings include AlphaLiquid, CancerDetect, and CancerFind. The firm was established by Tae-Yu Kim, Sung-Tae Moon, and Doo-Hee Bang on July 5, 2018, and maintains its headquarters in Seoul, South Korea.
Share Price
$2.15
Market Cap
$30.83M
Change (1 day)
0.81%
Change (1 year)
-61.85%
Country
KR
Trade IMBdx (461030)

Category

Stock split history for IMBdx (461030)
IMBdx stock (symbol: 461030) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 20, 2026.
One 461030 share bought prior to Aug 20, 2026 would equal to 0 461030 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH